Objective To investigate the factors influencing the liver histological features in chronic hepatitis B virus( HBV) infection patients with low alanine transaminase( ALT) levels by analyzing the relationship of serum hepatitis B surface antigen( HBs Ag) level with liver inflammation grade and fibrosis stage. Methods A total of 511 HBV infection patients admitted to our hospital from December 2010 to December 2013 were studied. The liver histological features,serum HBs Ag level,and HBV DNA copy number were examined. Comparison of categorical data between different groups was made by chi- square test,comparison of continuous data following the normal distribution was made by t test,and comparison of continuous data not following the normal distribution was made by Kruskal- Wallis H test. The relationship of serum HBs Ag level with liver inflammation grade and fibrosis stage was determined by Spearman's rank correlation analysis. Results All patients showed different degrees of hepatic histological abnormalities. The group aged more than or equal to 40 years had significantly lower HBe Ag positive rate,HBs Ag level,and HBV DNA copy number compared with the group aged less than 40 years( χ2= 86. 8,P <0. 000 1; t = 2. 99,P = 0. 003; t = 7. 25,P < 0. 000 1). The groups with different ages had significant differences in liver inflammation grade and fibrosis stage( χ2= 70. 03,P < 0. 000 1; χ2= 61. 92,P < 0. 000 1). The Spearman's rank correlation analysis indicated that in both HBe Ag- positive and- negative patients HBs Ag level was negatively correlated with liver inflammation grade( r =- 0. 245,P < 0. 000 1;r =- 1. 51,P = 0. 019) and fibrosis stage( r =- 0. 153,P = 0. 012; r =- 0. 181,P = 0. 005). Conclusion Age is one of the important factors influencing the liver histological progression in chronic HBV infection patients with low ALT levels. HBs Ag level is negatively correlated with liver inflammation grade and fibrosis stage in chronic HBV infection patients with low ALT levels,so it could be used as an important non- invasive indicator for the liver histological status in these patients.
[1] | Gengjie YAN, Yong LIN, Huiji SU, Hanxiao CHEN, Shaoqun BAN, Ailing WEI, Dewen MAO, Fuli LONG. Application and potential value of endogenous lipid mediators in liver failure[J]. Journal of Clinical Hepatology, 2023, 39(1): 211-217. doi: 10.3969/j.issn.1001-5256.2023.01.033 |
[2] | Mengyue SHANG, Yalin TONG, Yongzhong CHEN, Jie BAO. Influencing factors for acute kidney injury in acute liver failure and establishment of a predictive model[J]. Journal of Clinical Hepatology, 2023, 39(2): 359-364. doi: 10.3969/j.issn.1001-5256.2023.02.016 |
[3] | Weiyuan FANG, Yi LU. Diagnosis and treatment of acute liver failure in children with Wilson's disease[J]. Journal of Clinical Hepatology, 2022, 38(2): 268-272. doi: 10.3969/j.issn.1001-5256.2022.02.004 |
[4] | Luxiang HAN, Huixin TANG, Zhenfeng ZHAO, Shanshan LI, Quanyi WANG, Lingbin KONG, Huiying BI, Zhenfeng SHU, Zhongping DUAN, Yu CHEN, feng HONG. Effect of exosomes from adult human liver-derived stem cells on concanavalin A-induced acute liver injury in mice[J]. Journal of Clinical Hepatology, 2022, 38(5): 1101-1105. doi: 10.3969/j.issn.1001-5256.2022.05.024 |
[5] | Li JIANG, Huimin LIU, Qing MAO. IgG4-related autoimmune hepatitis with subacute liver failure as the initial manifestation: A case report[J]. Journal of Clinical Hepatology, 2022, 38(1): 170-173. doi: 10.3969/j.issn.1001-5256.2022.01.028 |
[6] | Xiaomei QIN, Shuangjie LI. Etiology, diagnosis, and treatment of acute liver failure in neonates[J]. Journal of Clinical Hepatology, 2022, 38(2): 260-263. doi: 10.3969/j.issn.1001-5256.2022.02.002 |
[7] | Nengli WANG, Xinbao XIE. Liver transplantation for pediatric acute liver failure[J]. Journal of Clinical Hepatology, 2022, 38(2): 278-281. doi: 10.3969/j.issn.1001-5256.2022.02.006 |
[8] | Xinbao XIE, Jianshe WANG. The diagnosis and treatment of pediatric acute liver failure should be taken seriously[J]. Journal of Clinical Hepatology, 2022, 38(2): 257-259. doi: 10.3969/j.issn.1001-5256.2022.02.001 |
[9] | Huan LIANG, Huiwen ZHANG. Inherited metabolic diseases causing acute liver failure in children[J]. Journal of Clinical Hepatology, 2022, 38(2): 273-277. doi: 10.3969/j.issn.1001-5256.2022.02.005 |
[10] | Xiaotong XU, Jinglan JIN. Death from acute hepatitis E in a non-pregnant middle-aged woman: A case report[J]. Journal of Clinical Hepatology, 2021, 37(4): 905-907. doi: 10.3969/j.issn.1001-5256.2021.04.036 |
[11] | Jingsheng MA, Yajun WU, Wentao YANG, Jiake HE, Hongfei ZHU, Yanfei RAO, Lin ZHONG, Qigen. LI. Successful liver transplantation in the treatment of acute liver failure caused by hemophagocytic syndrome: A case report[J]. Journal of Clinical Hepatology, 2021, 37(12): 2899-2901. doi: 10.3969/j.issn.1001-5256.2021.12.033 |
[12] | Fang YUAN, Jun SHI, Hailin TANG, Yiqun ZHOU, Fang XUE. HIV infection with acute liver failure as the main manifestation: A case report[J]. Journal of Clinical Hepatology, 2021, 37(7): 1670-1672. doi: 10.3969/j.issn.1001-5256.2021.07.039 |
[13] | Cao LiLi, Dong Yi, Xu ZhiQiang, Chen DaWei, Wang FuChuan, Gan Yu, Wang LiMin, Yan JianGuo, Wang Pu, Li AiQin, Zhang Min. Autosomal recessive polycystic kidney disease with congenital hepatic fibrosis: A report of 3 cases in a pedigree and literature review[J]. Journal of Clinical Hepatology, 2019, 35(1): 166-168. doi: 10.3969/j.issn.1001-5256.2019.01.033 |
[14] | Li ZhengXin, Xing Feng, Zhou Yang, Chen GaoFeng, Liu ChengHai. A case of congenital hepatic fibrosis with lgG4-related disease[J]. Journal of Clinical Hepatology, 2018, 34(10): 2192-2194. doi: 10.3969/j.issn.1001-5256.2018.10.026 |
[15] | Zhang Kai, Chen Hong, Lu MingXia, Wang FeiFei, Wan Hui, Zhang LiTing. One case of adult Still's disease with fever and jaundice as main clinical manifestations[J]. Journal of Clinical Hepatology, 2014, 30(6): 567-568. doi: 10.3969/j.issn.1001-5256.2014.06.023 |
[16] | Zhang AiMin, Xin ShaoJie. Virus infection and liver failure[J]. Journal of Clinical Hepatology, 2012, 28(10): 729-731. |